On the other hand, tumors treated with gemcitabine alone displayed an increase in STAT3 levels (Figure 5B, panel B); this effect has been observed in other studies and is suggested to be a potential contributor to gemcitabine resistance in pancreatic cancer cells [35,36]. This evidence concerns the gene STAT3 and familial pancreatic carcinoma.